Mount Lucas Management LP Bristol Myers Squibb CO Transaction History

Mount Lucas Management LP

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2023 Nov 14, 2023	SELL	$57.89 - $64.73 $15,109 - $16,894	-261 Reduced 0.72%	36,009 $2.09 Million
Q2 2023 Aug 14, 2023	SELL	$63.71 - $70.74 $312,370 - $346,838	-4,903 Reduced 11.91%	36,270 $2.32 Million
Q1 2023 May 12, 2023	BUY	$65.71 - $74.53 $133,654 - $151,594	2,034 Added 5.2%	41,173 $2.85 Million
Q4 2022 Feb 14, 2023	BUY	$68.48 - $81.09 $2.68 Million - $3.17 Million	39,139 New	39,139 $2.82 Million

2,533

1.47B

31.6M

35M

Ticker BMY
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,126,160,000
Market Cap $125B
Description
Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, and markets biopharmaceutical products worldwide. It offers products for hematology, oncology, cardiovascular, immunology, fibrotic, neuroscience, and covid-19 diseases. The company's products include Revlimid, an oral immunomodulatory drug for the treatment of multiple my...

Get notified when there are updates to the investment portfolio of Mount Lucas Management LP, based on Form 13F filings with the SEC.

Stay updated on Mount Lucas Management LP with notifications on news.